Growth Metrics

Idexx Laboratories (IDXX) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $374.8 million.

  • Idexx Laboratories' Non-Current Debt fell 2857.18% to $374.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.8 million, marking a year-over-year decrease of 2857.18%. This contributed to the annual value of $449.8 million for FY2024, which is 2778.96% down from last year.
  • Idexx Laboratories' Non-Current Debt amounted to $374.8 million in Q3 2025, which was down 2857.18% from $449.8 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Non-Current Debt peaked at $780.1 million during Q2 2021, and registered a low of $374.8 million during Q3 2025.
  • Its 5-year average for Non-Current Debt is $638.8 million, with a median of $694.4 million in 2022.
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 1167.02% in 2021, then crashed by 2857.18% in 2025.
  • Idexx Laboratories' Non-Current Debt (Quarter) stood at $775.2 million in 2021, then fell by 10.43% to $694.4 million in 2022, then decreased by 10.3% to $622.9 million in 2023, then dropped by 27.79% to $449.8 million in 2024, then fell by 16.67% to $374.8 million in 2025.
  • Its Non-Current Debt stands at $374.8 million for Q3 2025, versus $449.8 million for Q2 2025 and $449.8 million for Q1 2025.